Cannabis banking remains one of the industry’s most persistent challenges. Although most states permit cannabis in some form, federal restrictions continue to limit access to traditional banking, lending, and payment services.

That conflict has kept many large financial institutions on the sidelines. However, comments from JPMorgan Chase CEO Jamie Dimon suggest that the country’s largest bank could reconsider its position if federal law provides greater clarity.

Dimon’s remarks do not represent a commitment from JPMorgan to serve cannabis businesses. They do, however, show how federal reform could influence the policies of major banks and reshape the financial infrastructure available to state-licensed operators.

Editor’s note: This article has been updated to reflect federal cannabis policy developments through August 2026.

Why Cannabis Banking Remains Difficult

Cannabis businesses operate within overlapping state and federal regulatory systems.

States may license and regulate cannabis cultivation, manufacturing, distribution, and retail sales. Federal law, however, still restricts much of that activity. This conflict creates significant legal and compliance risks for financial institutions.

In April 2026, the Department of Justice moved FDA-approved marijuana products and products covered by qualifying state-issued medical cannabis licenses to Schedule III. The government also began a separate administrative process to consider the broader rescheduling of marijuana.

This was an important policy change, but it did not federally legalize adult-use cannabis or automatically provide banks with a comprehensive safe harbor.

Banks must continue complying with the Bank Secrecy Act, anti-money-laundering requirements, customer-identification rules, and federal reporting obligations. Serving a cannabis business can therefore require extensive due diligence and ongoing transaction monitoring.

What Jamie Dimon Said About Cannabis Banking

During a January 2025 episode of JPMorgan Chase’s podcast, The Unshakeables, Dimon discussed why the bank did not serve marijuana companies.

He attributed the decision to federal law and the compliance risks banks face when serving industries categorized as high-risk. When asked how JPMorgan might respond to a change in federal policy, Dimon said, “If there’s a federal law, we probably would.”

That statement was notable because JPMorgan Chase is the largest bank in the United States. It suggested that resistance from major financial institutions is driven less by a lack of commercial interest than by the legal uncertainty surrounding cannabis.

However, Dimon did not announce a cannabis banking program or provide a timeline for changing JPMorgan’s policies. His comments were conditional: meaningful federal reform would need to come first.

Why Major Banks Have Remained Cautious

Banking a cannabis company involves more than opening a standard business checking account.

Financial institutions must determine whether each customer holds the appropriate licenses, operates within state law, and maintains compliant ownership and financial records. They may also need to monitor transactions for activity that falls outside the company’s approved business model.

These requirements increase the cost and complexity of serving cannabis businesses. Banks may face regulatory scrutiny, fines, reputational concerns, and potential exposure under federal anti-money-laundering laws if their compliance programs are inadequate.

That risk explains why many large banks have chosen not to enter the market. Other institutions, including smaller banks and credit unions, have developed cannabis programs, but those services often require enhanced monitoring and higher fees.

The result is an uneven financial landscape in which licensed operators may have access to some banking services but not the complete range of products available to conventional businesses.

The SAFE Banking Act of 2026

Federal lawmakers have repeatedly introduced legislation intended to improve banking access for state-licensed cannabis businesses.

Previous proposals were commonly known as the SAFE Banking Act or SAFER Banking Act. Although versions advanced through congressional committees and passed the House on multiple occasions, none became law.

In June 2026, a bipartisan group of lawmakers introduced a new SAFE Banking Act of 2026. The proposal would protect qualifying financial institutions from federal penalties solely for serving cannabis businesses operating legally under state, tribal, or local laws.

The legislation would also clarify that proceeds from compliant cannabis activity are not automatically treated as unlawful funds for certain federal banking purposes.

Importantly, the bill would not require banks to work with cannabis companies. Financial institutions would still be able to evaluate customers according to their underwriting standards and risk policies.

As of August 2026, the legislation had been introduced but had not become law.

Does Schedule III Resolve the Banking Problem?

Moving qualifying medical cannabis products to Schedule III represents progress, but it does not eliminate the conflict between state cannabis programs and federal law.

Adult-use cannabis activity remains federally prohibited. State-licensed medical cannabis businesses must also continue operating within the boundaries of the new federal order and other applicable regulations.

Schedule III status may reduce certain tax and research barriers for qualifying medical cannabis activity. It does not provide the comprehensive legal protections banks need to serve the entire state-regulated industry without additional risk.

That is why supporters continue to advocate for the SAFE Banking Act even after the partial scheduling change. Rescheduling and banking reform address related but different problems.

How Limited Banking Access Affects Cannabis Businesses

Restricted access to banking affects nearly every part of a cannabis company’s operations.

Businesses that depend heavily on cash face greater security risks and more complicated reconciliation processes. Paying employees, vendors, taxes, and operating expenses can require additional time and resources.

Limited banking access can also make it harder to obtain loans, establish credit, or finance expansion. Even profitable cannabis businesses may face higher borrowing costs because fewer financial institutions are willing to serve the market.

Payment processing presents another challenge. Many traditional payment providers and card-based products remain unavailable to cannabis merchants, leading operators to explore specialized payment options designed for regulated markets.

These limitations affect more than dispensaries. Cultivators, manufacturers, distributors, landlords, professional service providers, and technology companies can all encounter financial restrictions because of their connection to the cannabis industry.

The Economic and Public-Safety Case for Reform

Supporters of cannabis banking reform frequently point to the risks created by cash-heavy operations.

Businesses that keep large amounts of currency on-site can become targets for theft and robbery. Employees may also need to transport cash to financial institutions or government offices, creating additional security concerns.

Bringing more cannabis revenue into monitored financial systems could improve transparency while making it easier for businesses to maintain records and pay taxes.

Greater banking access could also help licensed companies invest in employees, technology, new locations, and operational improvements. Smaller and independently owned businesses may benefit most because they often have fewer resources for managing complex financial workarounds.

What Cannabis Operators Should Do Now

Cannabis businesses should not assume that major banks will immediately enter the market following rescheduling or the introduction of new legislation.

Federal proposals can change, stall, or take considerable time to implement. Even after reform, banks may need to create new policies, establish compliance programs, and determine which cannabis business models they are willing to support.

Operators should continue working with financial and payment providers that understand cannabis regulations. Transparent ownership records, accurate financial statements, current licenses, clear product documentation, and strong compliance procedures can improve the stability of those relationships.

Payment redundancy is equally important. Depending entirely on one provider or payment method can expose a business to avoidable disruption. A diversified strategy may combine cash with compliant digital payment options and backup solutions appropriate for the company’s market.

The Role of Specialized Payment Providers

Specialized providers can help bridge the gap while traditional banking access remains limited.

Unlike general-purpose processors, cannabis-focused payment companies build their underwriting and monitoring practices around the realities of regulated businesses. This industry knowledge can help operators implement payment systems that support customer convenience without overlooking compliance.

PayRio provides payment solutions designed for cannabis and other regulated industries. Our approach emphasizes transparent underwriting, operational stability, and payment redundancy rather than relying on temporary workarounds.

As federal policy continues to evolve, cannabis businesses will need payment partners capable of adjusting to new regulatory and banking requirements.

What Dimon’s Comments Mean for the Industry

Jamie Dimon’s remarks matter because they reveal the conditions under which a major financial institution might reconsider cannabis.

JPMorgan Chase is not preparing to enter the market simply because cannabis is legal in many states. It is waiting for federal policy to provide sufficient legal and regulatory clarity.

Other national banks may take a similar approach. If Congress establishes clear protections, competition among financial institutions could increase, giving cannabis businesses access to more conventional accounts, lending products, and financial tools.

However, reform would not remove the need for careful underwriting. Cannabis would remain a closely regulated industry, and banks would still need to evaluate licensing, ownership, compliance, and transaction risks.

Conclusion

Cannabis banking has entered a new phase, but the industry has not yet achieved full access to traditional financial services.

Jamie Dimon’s comments suggest that JPMorgan Chase could consider serving cannabis companies if federal law changes. The partial move to Schedule III and the introduction of the SAFE Banking Act of 2026 represent meaningful developments, but neither has fully resolved the banking challenges facing the broader industry.

Until comprehensive reform arrives, cannabis operators must continue prioritizing compliance, transparency, and payment stability.

PayRio helps regulated cannabis businesses build payment strategies designed around these challenges. To learn more about creating reliable payment infrastructure for your operation, contact PayRio.